Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical diphencyprone for cutaneous metastatic or locally recurrent melanoma
ACTRN12609000475246Phase 2Completed
- Sponsor
- Royal Prince Alfred Hospital
- Start
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of diphencyprone in melanoma and cutaneous metastatic melanoma, sponsored by Royal Prince Alfred Hospital. Primary endpoint: Clinical clearance of cutaneous metastases. Started Jun 2009; status: completed.
02
Drugs
diphencyprone
03
Conditions
melanomacutaneous metastatic melanoma
Beyond the preview
Go deeper on ACTRN12609000475246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000475246.